Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Acute Kidney Injury Study
2012-004979-39Phase 2Active
- Sponsor
- VieCuri Medisch Centrum
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute kidney failure (AKF) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Improvement in endogenous creatinine clearance. Started Mar 2014; status: active.
02
Drugs
levosimendan
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2012-004979-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004979-39.